We wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e., 09-February''26 has considered and approved the unaudited standalone and consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 3.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Asarfi Hospital's Board of Directors, at its meeting on 9 February 2026, approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. The statutory auditor M/s R.K. Thakkar & Co. issued Limited Review Reports with an unmodified (clean) opinion on both standalone and consolidated results, confirming no material misstatements. Based on the cash flow extracts, standalone net profit after tax for 9MFY26 stood at about ₹1,298.34 lakhs (vs ₹1,097.97 lakhs for full FY25), while consolidated PAT was about ₹1,274.26 lakhs (vs ₹1,057.62 lakhs for FY25). Notably, net cash from operating activities turned sharply positive at around ₹1,086 lakhs standalone and ₹1,085 lakhs consolidated, compared to negative operating cash flows in FY25. The company operates in a single reportable segment (Hospital) and includes subsidiary Asarfi Educational Foundation in consolidated figures.
Clean audit opinion and a strong swing in operating cash flow from negative to positive are reassuring signs for shareholders, suggesting improved business performance and better working-capital management during 9MFY26.